Showing results (511-520 of 639) with videos related to
Sort By:
Pageof 64
Nano Letters|May 21, 2024
Quantitative Analogue Simulation of Planar MoleculesNileema Sharma, Sushrut Ghonge, Anthony Francisco, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2016
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside UptakeCristiane Metran-Nascente, Ivan Yeung, Douglass C Vines, et al.FEMS Microbiology Ecology|January 20, 2025
Importance, structure, cultivability, and resilience of the bacterial microbiota during infection of laboratory-grown Haematococcus spp. by the blastocladialean pathogen Paraphysoderma sedebokerense: evidence for a domesticated microbiota and its potential for biocontrolJeanne Miebach, David Green, Martina Strittmatter, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 4, 2012
Will working memory training generalize to improve off-task behavior in children with attention-deficit/hyperactivity disorder?Chloe T Green, Debra L Long, David Green, et al.Trials|December 6, 2017
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trialSimon P Hammond, Jane L Cross, Lee Shepstone, et al.Translational Psychiatry|October 24, 2019
Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's diseaseByron Creese, Evangelos Vassos, Sverre Bergh, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigmsKrista L Lanctôt, Joan Amatniek, Sonia Ancoli-Israel, et al.Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.Pageof 64